1. Guest, the two part 'News in Brief' for the week beginning 20th March 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

mella

Page 1 of 2
  1. SNT Gatchaman
    Thread

    Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, 2022, Rekeland et al

    Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients Rekeland IG, Sørland K,...
    Thread by: SNT Gatchaman, Sep 20, 2022, 43 replies, in forum: ME/CFS research
  2. Andy
    Thread

    No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for (ME/CFS), 2022, Ueland et al

    Full title: No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic...
    Thread by: Andy, Jul 13, 2022, 3 replies, in forum: ME/CFS research
  3. Kalliope
    Thread

    Open Pilot study in Norway - Daratumumab in ME/CFS

    Fluge et al are recruiting six moderate to severe ME patients for a pilot trial on Daratumumab. Participants need to be able to travel to...
    Thread by: Kalliope, Jun 14, 2022, 18 replies, in forum: Recruitment into current ME/CFS research studies
  4. strategist
    Thread

    Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, 2022,Hajdarevic et al

    Largest ME/CFS genetic study to date. Three different cohorts totaling more than 2500 patients. First Immunochip study in ME/CFS. Possible...
    Thread by: strategist, Mar 21, 2022, 56 replies, in forum: ME/CFS research
  5. Sly Saint
    Thread

    A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome, 2021, Fluge, Mella et al

    Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging...
    Thread by: Sly Saint, Aug 23, 2021, 31 replies, in forum: ME/CFS research
  6. Andy
    Thread

    Fine mapping of the major histocompatibility complex (MHC) in (ME/CFS) suggests involvement of both HLA class I and class II loci, 2021, Hajdarevic

    Full title: Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests...
    Thread by: Andy, Aug 18, 2021, 15 replies, in forum: ME/CFS research
  7. Sly Saint
    Thread

    Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS),2021,Fluge,Mella,Tronstad

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease with unknown etiology, no validated specific and sensitive biomarker, and...
    Thread by: Sly Saint, Jul 15, 2021, 31 replies, in forum: ME/CFS research
  8. jaded
    Thread

    Patent: Method for the treatment of CFS using an inhibitory or cytotoxic agent against plasma cells, 2021, Fluge, Mella

    I've just come across a patent from Fluge and Mella which looks like it was updated/published in March 2021 entitled 'Method for the treatment of...
    Thread by: jaded, Apr 24, 2021, 16 replies, in forum: ME/CFS research news
  9. John Mac
    Thread

    Reduced endothelial function in ME/CFS - results from open-label cyclophosphamide intervention study Fluge & Mella 2021

    Full title: Reduced endothelial function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - results from open-label cyclophosphamide...
    Thread by: John Mac, Mar 2, 2021, 20 replies, in forum: ME/CFS research
  10. Kalliope
    Thread

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    published in frontiers in Medicine - Family Medicine and Primary Care Results: The overall response rate by Fatigue score was 55.0% (22 of 40...
    Thread by: Kalliope, Apr 30, 2020, 129 replies, in forum: ME/CFS research
  11. Sly Saint
    Thread

    Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Fluge, Mella et al 2020

    Abstract The etiology and pathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are unknown, and autoimmunity is one of...
    Thread by: Sly Saint, Mar 26, 2020, 39 replies, in forum: ME/CFS research
  12. Kalliope
    Thread

    Christmas greeting from Olav Mella and Øystein Fluge via Fokus På ME

    Fokus på ME (Focus on ME) is a small Norwegian charity organising ME-conferences and fundraising for ME research by Olav Mella and Øystein Fluge...
    Thread by: Kalliope, Dec 22, 2019, 1 replies, in forum: General ME/CFS news
  13. Kalliope
    Thread

    Open Norway: Haukeland university hospital (Fluge/Mella) seeking ME-patients nearby Bergen to wear fitbit for 6 months

    Activity registration in ME/CFS Would you like to be part of developing new methods for future clinical trials? We are seeking participants for a...
    Thread by: Kalliope, Oct 2, 2019, 6 replies, in forum: Recruitment into current ME/CFS research studies
  14. Kalliope
    Thread

    Two new research projects received funds from the Norwegian ME Association May 12th

    The Norwegian ME Association donated on May 12th funds for two research projects. One of the research projects is by Fluge, Mella and their team....
    Thread by: Kalliope, May 15, 2019, 1 replies, in forum: ME/CFS research news
  15. Hip
    Thread

    Can the Giardia lamblia ME/CFS outbreak in Bergen explain why the phase II rituximab trials were positive, but the phase III trial negative?

    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SUMMARY: Could the positive results of the early Fluge & Mella 2011 blinded phase II rituximab trial...
    Thread by: Hip, Apr 22, 2019, 8 replies, in forum: Drug and supplement treatments
  16. Milo
    Thread

    B-Lymphocyte Depletion in Patients With ME/cfs: A Randomized, Double-Blind, Placebo-Controlled Trial (2019) Fluge et al

    B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial...
    Thread by: Milo, Apr 1, 2019, 82 replies, in forum: ME/CFS research
  17. Kalliope
    Thread

    Clinical Therapeutics: Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for CFS/ME - Rekeland,Mella et al

    Rituximab Serum Concentrations and Anti- Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome...
    Thread by: Kalliope, Nov 29, 2018, 4 replies, in forum: ME/CFS research
  18. Kalliope
    Thread

    Prof. Mella - Autoimmunity and metabolism in ME/CFS (lecture)

    Here is a lecture from prof. Olav Mella from a conference in Oslo November 2017. Language: Norwegian Subtitles: English Duration: 26 minutes...
    Thread by: Kalliope, Jan 25, 2018, 42 replies, in forum: General ME/CFS news
  19. Kalliope
    Thread

    Research Conference in Oslo 20-21 nov with Davis, Hornig & Mella

    Research Conference in Oslo 20 - 21. November 2017 The Norwegian ME Association is preparing a research conference in cooperation with Oslo...
    Thread by: Kalliope, Nov 2, 2017, 15 replies, in forum: General ME/CFS news
  20. adreno
    Thread

    Metabolic profiling indicates impaired pyruvate dehydrogenase function in ME/CFS, 2016, Fluge, Mella et al

    Another important one: Øystein Fluge, Olav Mella, et al. Abstract Myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is a debilitating...
    Thread by: adreno, Oct 31, 2017, 0 replies, in forum: ME/CFS research
Showing results 1 to 20 of 21
Page 1 of 2